TCG
DERM icon

Transcendent Capital Group’s Journey Medical DERM Stock Holding History

Transcendent Capital Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$2.82K – 471
2024
Q2 		$2.82K Buy
+500
New +$2.06K ﹤0.01% 374

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Transcendent Capital Group's DERM Position: Q3 2024 in Review

Transcendent Capital Group sold out of Journey Medical (DERM) in Q3 2024, closing a stake of 500 shares — an estimated $2.82K sold.

Transcendent Capital Group first reported a position in DERM in Q2 2024 and held it in 1 quarter. The position peaked at $2.82K in Q2 2024. 36 funds tracked by Wall St. Rank hold DERM as of Q3 2024.

  • Transcendent Capital Group reported no remaining Journey Medical position as of Q3 2024 after selling out during the quarter.
  • Transcendent Capital Group sold 500 Journey Medical shares in Q3 2024, an estimated $2.82K.
  • Transcendent Capital Group first reported a position in Journey Medical in Q2 2024 and held it in 1 quarter.
  • Transcendent Capital Group's Journey Medical position peaked at $2.82K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held Journey Medical as of Q3 2024.

Based on Transcendent Capital Group's 13F filing for Q3 2024, filed 1 Nov 2024.